Cargando…
Exosomes from bone marrow mesenchymal stem cells are a potential treatment for ischemic stroke
[Image: see text] Exosomes derived from human bone marrow mesenchymal stem cells (MSC-Exo) are characterized by easy expansion and storage, low risk of tumor formation, low immunogenicity, and anti-inflammatory effects. The therapeutic effects of MSC-Exo on ischemic stroke have been widely explored....
Autores principales: | Liu, Chang, Yang, Tian-Hui, Li, Hong-Dan, Li, Gong-Zhe, Liang, Jia, Wang, Peng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer - Medknow
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10328279/ https://www.ncbi.nlm.nih.gov/pubmed/37056144 http://dx.doi.org/10.4103/1673-5374.369114 |
Ejemplares similares
-
Exosomes Derived from Bone Marrow Mesenchymal Stem Cells Promote Angiogenesis in Ischemic Stroke Mice via Upregulation of MiR-21-5p
por: Hu, Hui, et al.
Publicado: (2022) -
Chitosan-collagen porous scaffold and bone marrow mesenchymal stem cell transplantation for ischemic stroke
por: Yan, Feng, et al.
Publicado: (2015) -
Bone marrow mesenchymal stem cell therapy in ischemic stroke: mechanisms of action and treatment optimization strategies
por: Li, Guihong, et al.
Publicado: (2016) -
Exosomes derived from bone marrow mesenchymal stem cells protect the injured spinal cord by inhibiting pericyte pyroptosis
por: Zhou, Yan, et al.
Publicado: (2021) -
Bone marrow mesenchymal stem cells transplantation promotes the release of endogenous erythropoietin after ischemic stroke
por: Lv, Wen, et al.
Publicado: (2015)